Valganciclovir Tablets — Class II drug recall D-0601-2018
Terminated recall by Hetero Labs Limited Unit V, reported 2018-03-21, distributed nationwide. Temperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were exposed to highe
| Recall number | D-0601-2018 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hetero Labs Limited Unit V, Jadcherla Mandal, Mahaboob Nagar, India |
| Recall initiated | 2018-02-13 |
| Classified | 2018-03-16 |
| Reported by FDA | 2018-03-21 |
| Terminated | 2021-02-18 |
| Distributed | Nationwide (US) |
| Reason classes | temperature control |
| NDC | 31722-0832, 31722-0832-31, 31722-0832-32, 31722-0832-60 |
| Lot numbers | VGC17040, VGC17041 |
| Expiration dates | 2019-07 |
Product
Valganciclovir Tablets, USP, 450 mg, 60-count bottle, Rx Only, Manufactured for Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, By: Hetero Hetero Labs Limit Unit V Pollypally Jadcherla Mahaboob Nagar - 509 301 India. NDC # 31722-832-60
Reason for recall
Temperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or cargo and in the same consignment of Famciclovir complaint batch (D-0415-2018).
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0601-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.